Prevalence and factors associated with hyperglycemia among children living with HIV on dolutegravir in Kabale district, southwestern Uganda
View abstract on PubMed
Summary
This summary is machine-generated.Hyperglycemia affects one in five children with HIV on dolutegravir (DTG) treatment in Uganda. Adolescents and children consuming red meat showed higher risks, indicating a need for regular blood sugar monitoring.
Area Of Science
- Pediatrics
- Infectious Diseases
- Endocrinology
Background
- High blood sugar (hyperglycemia) poses significant health risks for children, especially those with undiagnosed or poorly managed conditions.
- Antiretroviral therapy (ART) including dolutegravir (DTG) has been linked to increased hyperglycemia prevalence in adults with HIV.
- Limited data exists on hyperglycemia in children living with HIV who are on DTG-based ART in Uganda.
Purpose Of The Study
- To determine the prevalence of hyperglycemia among children living with HIV on DTG in Uganda.
- To identify factors associated with hyperglycemia in this pediatric population.
Main Methods
- A cross-sectional study involving 271 children under 18 years old receiving DTG-based ART in Kabale district, Uganda.
- Data collection via structured questionnaires and biochemical tests (random blood sugar, HbA1C).
- Statistical analysis using logistic regression to identify associated factors.
Main Results
- The prevalence of hyperglycemia was 20.3% among the studied children.
- Of those with hyperglycemia, 76% had prediabetes and 24% had diabetes mellitus.
- Independent factors associated with hyperglycemia included red meat consumption (AOR: 3.52) and age over 13 years (AOR: 2.61).
Conclusions
- One in five children with HIV on DTG treatment exhibit hyperglycemia, with a significant proportion having diabetes mellitus.
- Adolescents and children consuming red meat are more susceptible to hyperglycemia.
- Routine blood glucose monitoring is recommended for children with HIV on DTG therapy.
Related Concept Videos
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

